Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment

  • Rawal S
  • Chu F
  • Zhang M
  • et al.
81Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

Abstract

The microenvironment of human follicular lymphoma (FL), an incurable B cell non-Hodgkin’s lymphoma, is thought to play a major role in its pathogenesis and course. Microenvironmental cells of likely importance include follicular Th cells (TFH) and regulatory T cells (Tregs), and understanding their interactions with FL tumor cells is necessary to develop novel therapeutic strategies. We found that IL-4 and CD40L are expressed by intratumoral TFH and induce production of CCL17 and CCL22 by FL tumor cells. IL-4 alone induces only CCL17 but enhances stimulation by CD40L of both CCL17 and CCL22. Consistent with our in vitro results, mRNA transcripts of IL-4 correlated with CCL17, but not CCL22, in gene expression profiling studies of FL biopsies, whereas CD40L correlated with both CCL17 and CCL22. Tumor supernatants induced preferential migration of Tregs and IL-4–producing T cells rather than IFN-γ–producing T cells, and Abs to CCR4 significantly abrogated the migration of Tregs. Our results suggest that through two distinct mechanisms, intratumoral TFH induce production of CCL17 and CCL22 by FL tumor cells and facilitate active recruitment of Tregs and IL-4–producing T cells, which, in turn, may stimulate more chemokine production in a feed-forward cycle. Thus, TFH appear to play a major role in generating an immunosuppressive tumor microenvironment that promotes immune escape and tumor survival and growth. Our results provide novel insights into the cross talk among TFH, tumor cells, and Tregs in FL, and offer potential targets for development of therapeutic strategies to overcome immune evasion.

References Powered by Scopus

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program

2652Citations
N/AReaders
Get full text

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

2320Citations
N/AReaders
Get full text

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1891Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: A single group, open-label, phase 2 trial

486Citations
N/AReaders
Get full text

Pathophysiology of T follicular helper cells in humans and mice

359Citations
N/AReaders
Get full text

In situ vaccination with a tlr9 agonist and local low-dose radiation induces systemic responses in untreated indolent lymphoma

143Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Rawal, S., Chu, F., Zhang, M., Park, H. J., Nattamai, D., Kannan, S., … Neelapu, S. S. (2013). Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment. The Journal of Immunology, 190(12), 6681–6693. https://doi.org/10.4049/jimmunol.1201363

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 33

54%

Researcher 20

33%

Professor / Associate Prof. 7

11%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

35%

Agricultural and Biological Sciences 16

26%

Biochemistry, Genetics and Molecular Bi... 12

19%

Immunology and Microbiology 12

19%

Save time finding and organizing research with Mendeley

Sign up for free